Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

8(88.9%)

Phase 3

1(11.1%)

9Total

N/A(8)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05590195Phase 3Unknown

Effect of PreforPro® on Urinary and Vaginal Health

Role: collaborator

NCT04917913Not ApplicableUnknown

Efficacy of a Digestive Enzyme Blend

Role: lead

NCT04758845Not ApplicableUnknown

Clinical Study to Evaluate the Safety and Efficacy of New Probiotic Strains in Health Adults

Role: lead

NCT04144777Not ApplicableCompleted

Efficacy of Solarplast for Health and Oxidative Stress

Role: lead

NCT04489836Not ApplicableCompleted

GlutDigest - Pilot Study

Role: lead

NCT04491188Not ApplicableCompleted

Plasma Amino Acid Response to Whey Protein Ingestion Following 28-days of Probiotic Supplementation

Role: collaborator

NCT04144114Not ApplicableCompleted

The Effect of ProHydrolase® on the Amino Acid, Intramuscular Anabolic Signaling, and Endocrine Response to Resistance Exercise in Trained Males

Role: lead

NCT04083521Not ApplicableCompleted

Effect of Bacillus Subtilis DE111® on Daily Bowel Movements

Role: lead

NCT04077034Not ApplicableCompleted

Effect of Probiotic Formula DE111® on Immune System in Preschool Children

Role: lead

All 9 trials loaded